文献速递生殖医学

外显子组测序将CEP120突变与母源性非整倍体胚胎风险相关联

Exome sequencing links CEP120 mutation to maternally derived aneuploid conception risk.
PubMed 文献 · Hum Reprod · 2020-01-01

该研究对166例接受生育治疗的患者进行全外显子组测序,比较非整倍体囊胚数高与低的患者,发现高非整倍体组在细胞骨架和微管通路基因中突变负荷更高。在小鼠卵母细胞中验证CEP120变异rs2303720可导致纺锤体微管成核效率下降和非整倍体发生率增加。

要点

  • 高非整倍体囊胚患者携带细胞骨架和微管通路基因的突变负荷更高。
  • CEP120变异rs2303720在小鼠卵母细胞中导致纺锤体微管成核效率降低和非整倍体增加。
  • 作者认为中心体基因变异可能是母源性非整倍体的重要贡献因素。

核心结论

  • CEP120非同义变异rs2303720在体外小鼠中破坏雌性减数分裂。
  • 中心体基因变异似乎是母源性非整倍体风险的重要贡献因素。

研究设计与样本

  • 对166例接受生育治疗的患者进行去标识化全外显子组测序。
  • 患者自我认定为白人非西班牙裔,年龄22至49岁,分为对照组97例和病例组69例。
  • 根据每次IVF过程中产生的非整倍体囊胚数量分组。
  • 采用基因优先排序策略后,使用小鼠卵母细胞系统验证发现的遗传变异的功能意义。

主要发现

  • 产生高比例非整倍体囊胚的患者在细胞骨架和微管通路基因中携带更高的突变负荷。
  • 非整倍体囊胚定义为缺失40条染色单体中的任何一条或具有额外拷贝。
  • 小鼠卵母细胞中异位表达CEP120:p.Arg947His导致纺锤体微管成核效率下降和非整倍体发生率增加。

局限性

  • 功能验证使用小鼠卵母细胞系统。
  • 小鼠和人类卵母细胞的纺锤体构建通路不同,异位表达Cep120变异所观察到的缺陷对小鼠卵母细胞减数分裂的影响可能与对人类卵母细胞减数分裂的影响不同。
  • 需要使用敲入「人源化」小鼠模型和人类卵母细胞进行进一步研究以将发现转化至人类系统。
  • 该变异在不同种族群体之间可能的功能差异也需要研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What are the genetic factors that increase the risk of aneuploid egg production? SUMMARY ANSWER: A non-synonymous variant rs2303720 within centrosomal protein 120 (CEP120) disrupts female meiosis in vitro in mouse. WHAT IS KNOWN ALREADY: The production of aneuploid eggs, with an advanced maternal age as an established contributing factor, is the major cause of IVF failure, early miscarriage and developmental anomalies. The identity of maternal genetic variants contributing to egg aneuploidy irrespective of age is missing. STUDY DESIGN, SIZE, DURATION: Patients undergoing fertility treatment (n = 166) were deidentified and selected for whole-exome sequencing. PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients self-identified their ethnic groups and their ages ranged from 22 to 49 years old. The study was performed using genomes from White, non-Hispanic patients divided into controls (97) and cases (69) according to the number of aneuploid blastocysts derived during each IVF procedure. Following a gene prioritization strategy, a mouse oocyte system was used to validate the functional significance of the discovered associated genetic variants. MAIN RESULTS AND THE ROLE OF CHANCE: Patients producing a high proportion of aneuploid blastocysts (considered aneuploid if they missed any of the 40 chromatids or had extra copies) were found to carry a higher mutational burden in genes functioning in cytoskeleton and microtubule pathways. Validation of the functional significance of a non-synonymous variant rs2303720 within Cep120 on mouse oocyte meiotic maturation revealed that ectopic expression of CEP120:p.Arg947His caused decreased spindle microtubule nucleation efficiency and increased incidence of aneuploidy. LIMITATIONS, REASONS FOR CAUTION: Functional validation was performed using the mouse oocyte system. Because spindle building pathways differ between mouse and human oocytes, the defects we observed upon ectopic expression of the Cep120 variant may alter mouse oocyte meiosis differently than human oocyte meiosis. Further studies using knock-in 'humanized' mouse models and in human oocytes will be needed to translate our findings to human system. Possible functional differences of the variant between ethnic groups also need to be investigated. WIDER IMPLICATIONS OF THE FINDINGS: Variants in centrosomal genes appear to be important contributors to the risk of maternal aneuploidy. Functional validation of these variants will eventually allow prescreening to select patients that have better chances to benefit from preimplantation genetic testing. STUDY FUNDING/COMPETING INTEREST(S): This study was funded through R01-HD091331 to K.S. and J.X. and EMD Serono Grant for Fertility Innovation to N.R.T. N.R.T. is a shareholder and an employee of Genomic Prediction. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Tyc KM, El Yakoubi W, Bag A, et al. Exome sequencing links CEP120 mutation to maternally derived aneuploid conception risk. Hum Reprod. 2020. PMID: 32772081. doi:10.1093/humrep/deaa148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。